rs199473434
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM1PP3PP5BS2_Supporting
The NM_000238.4(KCNH2):c.2684C>T(p.Thr895Met) variant causes a missense change. The variant allele was found at a frequency of 0.0000301 in 1,230,738 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T895T) has been classified as Likely benign.
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2684C>T | p.Thr895Met | missense_variant | 11/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.2684C>T | p.Thr895Met | missense_variant | 11/15 | 1 | NM_000238.4 | ENSP00000262186 | P1 | |
KCNH2 | ENST00000330883.9 | c.1664C>T | p.Thr555Met | missense_variant | 7/11 | 1 | ENSP00000328531 | |||
KCNH2 | ENST00000684241.1 | n.3517C>T | non_coding_transcript_exon_variant | 9/13 |
Frequencies
GnomAD3 genomes AF: 0.0000535 AC: 7AN: 130820Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000205 AC: 5AN: 243318Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132456
GnomAD4 exome AF: 0.0000273 AC: 30AN: 1099880Hom.: 0 Cov.: 35 AF XY: 0.0000291 AC XY: 16AN XY: 550626
GnomAD4 genome AF: 0.0000535 AC: 7AN: 130858Hom.: 0 Cov.: 30 AF XY: 0.0000161 AC XY: 1AN XY: 62152
ClinVar
Submissions by phenotype
Long QT syndrome 2 Pathogenic:1Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | DASA | Jun 10, 2022 | The c.2684C>T;p.(Thr895Met) missense change has been observed in affected individual(s)(PMID: 26129877; 18596570; 23304551; 21215473; 20674198) - PS4.Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 26129877; 18596570) - PS3_supporting. The variant is present at low allele frequencies population databases (rs199473434– gnomAD 0.0005351%; ABraOM no frequency - http://abraom.ib.usp.br/) -PM2_supporting. Multiple lines of computational evidence support a deleterious effect on the gene or gene product - PP3. In summary, the currently available evidence indicates that the variant is Likely Pathogenic - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Long QT syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Nov 30, 2023 | This missense variant replaces threonine with methionine at codon 895 of the KCNH2 protein. Computational prediction tools and conservation analyses are inconclusive regarding the impact of this variant on the protein function. Computational splicing tools suggest that this variant may not impact RNA splicing. An electrophysiological study in cell culture has shown that this variant may affect the deactivation time course of the potassium channels (PMID: 26129877). However, clinical relevance of this observation is not clear. This variant has been reported in an individual affected with atrial fibrillation, as well as in the proband's father and son affected with paroxysmal palpitations (PMID: 26129877). This variant has been reported in an infant affected with sudden death syndrome (PMID: 18596570). This variant has also been identified in 6/273882 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 895 of the KCNH2 protein (p.Thr895Met). This variant is present in population databases (rs199473434, gnomAD 0.01%). This missense change has been observed in individual(s) with atrial fibrillation and in two relatives with paroxysmal palpitations (PMID: 18596570, 26129877). ClinVar contains an entry for this variant (Variation ID: 67426). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects KCNH2 function (PMID: 18596570, 26129877). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Long QT syndrome 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute | May 17, 2020 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 06, 2020 | Identified in a Japanese patient with sudden infant death syndrome who also harbored a variant in the SCN5A gene (Otagiri et al., 2008); Identified in a Japanese man, his father, and his son, all of whom were affected with persistent or paroxysmal palpitations; the proband's ECG showed a normal QTc interval (Hayashi et al., 2015); Published functional studies suggested a gain-of-function effect (Otagiri et al., 2008; Hayashi et al., 2015); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31043699, 18596570, 26129877, 22581653, 26332594, 22995991) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 28, 2022 | The c.2684C>T (p.T895M) alteration is located in exon 11 (coding exon 11) of the KCNH2 gene. This alteration results from a C to T substitution at nucleotide position 2684, causing the threonine (T) at amino acid position 895 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 16, 2023 | This missense variant replaces threonine with methionine at codon 895 of the KCNH2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). In vitro functional studies have shown that this variant may affect the amplitude of current and causes a delay in deactivation of the potassium channels (PMID: 18596570, 26129877). This variant has been reported in an individual affected with atrial fibrillation, as well as in the proband's father and son affected with paroxysmal palpitations (PMID: 26129877). This variant has also been reported in an infant affected with sudden death syndrome (PMID: 18596570), and in two individuals suspected of having epilepsy (PMID: 31696929). This variant has also been identified in 6/273882 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
SUDDEN INFANT DEATH SYNDROME Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Sudden infant death syndrome in the following publications (PMID:18596570). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at